Chapter 26 - New Experiments for a New Century

Every chapter of Part IV so far has introduced a technology and sketched, in appropriately bounded terms, what it could contribute to morphic resonance research. This chapter's job is different and harder: to assemble those individual components into complete, end-to-end experimental protocols - the kind of fully specified research designs that could actually be submitted as a grant proposal, a doctoral thesis plan, or a registered report, rather than remaining a collection of promising but disconnected technical possibilities. What follows are four complete protocols, each targeting a different domain from Part II, each incorporating the methodological lessons of every preceding chapter in this Part. The first three are designed to meet this book's concrete, symmetrical bar for a decisive experiment: pre-registered, adversarially co-designed, automated at scale, tested against a calibrated conventional baseline, and committed to publication regardless of outcome. The fourth is different in kind - not a direct test of morphic resonance, but a test of whether a conventional local mechanism already accounts for a specific claimed anomaly, which the reordering proposed in Chapter 15 argues should come first.

Protocol One: The Global Crystallization Consortium

This protocol directly answers the unfinished crystallization test proposed earlier in this book - the genuinely novel-compound test that has never, to my knowledge, been conducted with full rigor.

1. Consortium formation. A minimum of four independent, geographically distributed pharmaceutical or academic crystallography laboratories, none of which has any shared personnel, equipment, or shipping history within the preceding two years, agree in advance, through a formal adversarial-collaboration structure - proponent and skeptic jointly designing and signing off, in the Wiseman-Schlitz spirit - before any data collection begins.

2. Compound selection and synthesis. A genuinely novel organic compound - one with no prior existence anywhere on Earth, synthesized specifically for this study - is independently produced at each site, using independently sourced precursor chemicals, in clean-room facilities meeting a jointly specified contamination-control standard (minimum ISO Class 7, with certified air filtration at the sub-micron scale).

3. Instrumentation. Each site uses in-line Raman spectroscopy and automated high-throughput crystallization screening robots - already standard equipment in modern pharmaceutical process-chemistry labs, repurposed here rather than newly built - to continuously monitor, with second-by-second resolution, every crystallization attempt, feeding the resulting time-series data into a shared, pre-registered analysis pipeline.

4. Sequencing and blinding. Sites attempt initial crystallization in a staggered, randomized, and blinded sequence: a central coordinating team, uninvolved in any actual laboratory work, controls the release timing of synthesized compound batches to each site according to a pre-generated random schedule, and no site is informed of any other site's crystallization status until the full dataset is collected and locked.

5. Conventional baseline. Before unblinding, the coordinating team builds a fully specified conventional baseline model using digital-twin methodology, incorporating known thermodynamic nucleation theory, quantum-simulation-derived nucleation-energy estimates, and rigorous documentation of the extremely low but non-zero probability of contamination even under clean-room conditions.

6. Primary outcome measure and power. Time-to-first-crystallization at each site, measured from the start of controlled cooling to first detected nucleation event, in hours. Based on the range of nucleation-barrier variability documented in the existing polymorphism literature, detecting a 20% reduction in time-to-crystallization at the second and subsequent sites relative to the calibrated baseline, at conventional statistical power (80%, α = 0.05), requires roughly 40 to 60 independent crystallization attempts per site - achievable with the automated high-throughput screening robots specified above running parallel batches, within a two-to-three-month data collection window per site.

7. Pre-registered significance threshold. The exact statistical threshold for a "positive" and "negative" result is agreed jointly and publicly, in writing, before unblinding, via a registered report submitted to a journal committed to publication regardless of outcome.

8. Cost and feasibility. A genuinely expensive protocol - plausibly $800,000 to $2.5 million, depending on how much clean-room and instrumentation time must be purchased versus contributed in-kind by partner institutions. Every individual component is standard commercial pharmaceutical infrastructure, meaning the primary barrier is securing multi-institutional buy-in and funding for a study whose commercial upside accrues to no single funder - exactly the "public good" research funding gap this book has flagged before. Plausible funding partners include national science foundations' basic-research divisions, university-affiliated crystallography core facilities with existing unused capacity, and, for the compound synthesis and initial screening stages specifically, pharmaceutical companies with an interest in polymorphism risk management for entirely conventional commercial reasons, who might contribute in-kind facility time in exchange for co-authorship and early access to any resulting improvements in nucleation-prediction methodology.

Protocol Two: The Automated Global Perception Study

This protocol directly answers the automation gap identified earlier in this book's discussion of the staring-detection and telephone-telepathy literature.

1. App development. A mobile application, developed collaboratively by proponent and skeptical researchers under the same adversarial-collaboration structure as Protocol One, delivers a fully automated version of a staring-detection-style perceptual protocol, with every component that previously depended on a live human experimenter replaced by automated apparatus: randomized trial timing generated by a cryptographically secure random number generator, "starer" behavior triggered and verified by a paired app instance with camera-based gaze-direction confirmation, and subject responses collected via simple, unambiguous forced-choice button presses, with millisecond-precision timestamping throughout.

2. Recruitment and partnership. Subject recruitment through partnership with an existing large-scale citizen-science platform - several such platforms, built for entirely unrelated psychological and cognitive research, already maintain millions of registered, consented participants, making a formal data-sharing and research-ethics partnership the realistic path to scale rather than recruiting from zero.

3. Primary outcome measure and power. Hit rate on the forced-choice staring/no-staring judgment, against a chance baseline of 50%. The historical literature reports effects in the 53–55% range; a well-powered study should be designed to detect effects considerably smaller than this, both because automation should shrink or eliminate any real experimenter-cuing contribution to the historical effect, and because a smaller, more credible effect size is the more realistic target given the file-drawer concerns this book has raised throughout. Detecting a 1-percentage-point deviation from chance at 80% power requires approximately 130,000 trials; detecting a 0.5-percentage-point deviation requires approximately 520,000 trials. Given that each participant can complete dozens of trials in a single app session, a subject pool of 5,000 to 15,000 consenting participants, each completing 40–100 trials over several sessions, is sufficient to reach the higher end of this range within a single data collection period.

4. Confound control. The app's metadata - device location, self-reported and inferred social-network connections between paired users, prior app usage history - is used to statistically model and, where possible, explicitly exclude any pairs of subjects with plausible conventional acquaintance, directly addressing this book's "genuine isolation" requirement for a decisive experiment in a way no prior study in this literature has been able to verify at scale.

5. Analysis. Following the machine-learning-based confound modeling introduced earlier, the analysis pipeline explicitly models and statistically controls for every conventional variable available in the metadata - time of day, device type, subject demographics, prior trial performance, "starer" and "guesser" familiarity with the app - before testing for any residual deviation from the chance baseline, with the complete model architecture and statistical thresholds pre-registered before data collection begins.

6. Cost and feasibility. The least expensive of the first three protocols by a wide margin, though not the least expensive in this chapter overall - see Protocol Four below: app development, cloud infrastructure, and a data-sharing partnership with an existing citizen-science platform, plausibly $150,000 to $400,000 total, well within range of a standard psychology or cognitive science research grant, and realistically executable by a single well-supported research team rather than requiring the multi-institutional consortium Protocol One needs.

Protocol Three: The Cross-Population Novel-Skill Acquisition Study

This protocol directly answers the human-scale extension of the McDougall rat paradigm proposed earlier, in the discussion of educational technology platforms.

1. Platform partnership and module design. In partnership with one or more existing online skill-acquisition platforms - language learning, musical instrument training, or programming education platforms are all plausible partners, given their existing fine-grained, timestamped user performance data - researchers introduce a genuinely novel learning module: a specific skill, exercise sequence, or problem type that has never previously existed on the platform or, ideally, anywhere in the public educational record, verified through language-model-based novelty detection.

2. Staggered rollout. The module releases to different user cohorts on a carefully staggered, geographically stratified schedule, with the platform's existing infrastructure automatically collecting millisecond-precise attempt, error, and completion-time data for every user who encounters it.

3. The critical control. A subset of "late" cohorts receives a version of the module deliberately held constant, with no platform-side refinements applied and no access to any aggregate performance data or hints derived from earlier cohorts - isolating whether individual learning speed improves across cohorts even when every conventional, platform-mediated channel of improvement is explicitly blocked. This is the single design element that separates this protocol from an easily-confounded observational comparison: without it, any observed improvement across cohorts is equally explicable by ordinary platform refinement, and the study proves nothing.

4. Primary outcome measure and power. Number of attempts to reach a defined mastery criterion for the novel module, compared between early and matched "held-constant" late cohorts. Given typical variance in skill-acquisition speed on existing educational platforms, detecting a 5% reduction in attempts-to-mastery at 80% power requires cohorts of roughly 8,000 to 12,000 users each - well within the daily active user counts of major educational platforms, meaning the required sample could plausibly be collected within a single month of normal platform operation once the module is live.

5. Analysis. A digital twin of the platform's own historical learning-curve data is built and validated on entirely separate, existing modules before the novel module's data is examined, ensuring the conventional baseline model is properly calibrated to this specific platform's real user population and existing dynamics before any claim about a residual anomaly can be entertained.

6. Cost and feasibility. Primarily a partnership and data-engineering cost rather than a hardware or facility cost: plausibly $100,000 to $300,000 for the research team's time, data pipeline construction, and the module design and novelty-verification work, plus whatever the platform partner requires in exchange for participation - commonly, in comparable computational social science collaborations, co-authorship and a summary report on findings relevant to the platform's own product goals (in this case, exactly the kind of "does staggered rollout affect learning outcomes independent of content refinement" question that has direct commercial relevance to the platform's own curriculum design, giving a real, non-charitable reason for a platform to participate).

Protocol Four: The Bioelectric Baseline Study

This protocol is different in kind from the first three, and it belongs here precisely because of the reordering Chapter 15 asked you to carry forward: before chasing a non-local signal, rule out a local one that mainstream biology has already shown is real. Where Protocols One through Three are designed to detect a residual anomaly after every conventional explanation has been exhausted, Protocol Four is designed to test whether a specific category of claimed anomaly - developmental or regenerative outcomes that appear to exceed what genetics alone predicts - is instead fully explained by bioelectric pattern memory of the kind Michael Levin's research program has documented.

1. Target selection. Choose a specific, well-documented instance from the historical morphic resonance literature, or from Part II of this book, where a developmental or regenerative outcome has been described as difficult to fully explain genetically - regenerative variability in planarian populations is the natural first candidate, given how directly Chapter 15 engages with exactly this organism.

2. Bioelectric mapping. Using voltage-sensitive fluorescent dyes and standard optical imaging, map the bioelectric pattern across the regenerating tissue at fine time resolution, for a large sample of individual animals - technology and protocols already established and published by Levin's group and others, requiring no novel instrumentation development.

3. The comparative test. For each individual animal in the sample, determine whether its specific regenerative outcome - normal single-headed regeneration, or a variant outcome - is predicted more accurately by its measured bioelectric pattern alone, by its genomic and epigenetic profile alone, or by neither, leaving a genuine residual to investigate further. This is a direct, statistically tractable horse race between three candidate predictors, not a qualitative argument.

4. Primary outcome measure and power. Predictive accuracy (area under the ROC curve) of each candidate predictor for a binary or categorical developmental outcome. Given typical effect sizes in the published bioelectric-signaling literature, distinguishing a bioelectric-driven predictor from a genomic-only predictor at 80% power requires a sample in the range of 300 to 500 individual animals - modest by the standards of the other three protocols, and achievable within a single well-equipped developmental biology lab in under a year.

5. Cost and feasibility. By far the least expensive and most immediately achievable of the four protocols: $40,000 to $120,000, well within a standard developmental biology start-up grant, requiring no novel infrastructure and no multi-institutional consortium. This is, deliberately, the protocol in this chapter with the lowest barrier to entry, because it directly tests the reordering this book's research agenda asks you to take seriously, and because a graduate student with access to any developmental biology lab already running planarian or amphibian regeneration work could plausibly execute a pilot version of it within a single semester.

Protocol Comparison

The Common Thread: A Reusable Template

Look back across these four protocols and you'll notice a shared structural template, deliberately so - a reusable design pattern rather than four isolated examples. Every protocol: (1) is built from existing, currently available infrastructure and instrumentation, minimizing novel technology risk; (2) uses adversarial, jointly-designed collaboration between proponents and skeptics to preempt post-hoc bias-of-execution disputes of exactly the kind that dogged the Sheldrake-Wiseman-Blackmore controversies surveyed in Part II; (3) achieves sample sizes many orders of magnitude larger than any historical study in this literature, through automation rather than expanded human labor; (4) builds and validates a fully specified, quantitative conventional baseline model, using digital-twin and simulation methods, before any claim about a residual anomaly is entertained; and (5) commits, through formal pre-registration, to publishing the complete result regardless of outcome. This five-part template - existing infrastructure, adversarial co-design, automated scale, validated conventional baseline, pre-committed publication - is the single most valuable transferable output of this entire Part, applicable well beyond the four specific protocols sketched here.

It's worth being explicit about why Protocol Four belongs in the same chapter as the other three, rather than sitting off to the side as a different kind of project entirely. A funder or a doctoral committee evaluating any one of Protocols One through Three should reasonably ask: has the specific claimed anomaly this protocol is designed to detect already been ruled out, or already been explained, by a conventional local mechanism nobody has checked for? Protocol Four is the general-purpose answer to that question, built to be run cheaply and quickly, ahead of the larger and more expensive studies, as a filter rather than a competitor. A research portfolio that runs Protocol Four first, on whatever domain its available infrastructure best supports, and only proceeds to the more expensive protocols once the local-mechanism explanation has genuinely been exhausted, is a portfolio that spends its scarcest resource - credibility - more wisely than one that jumps straight to the dramatic experiment. This is, in miniature, the entire argument of Chapter 15 translated into funding strategy.

Questions for the Curious

• Select one of the four protocols above and write a full, formal grant proposal or registered-report submission, refining the power analysis and budget estimates given here with real, sourced current pricing for the required instrumentation, cloud infrastructure, or platform partnership.

• Identify a specific, real existing educational technology platform, citizen-science platform, developmental biology lab, or pharmaceutical/academic crystallography consortium that could plausibly serve as a partner for one of these protocols, and draft an outreach proposal explaining the scientific and, where relevant, reputational or product-improvement value the partnership could offer them.

• Design a full pre-registration document, using the Open Science Framework's registered-report template as a model, for a novel fifth protocol of your own design, targeting any domain covered in Part II that the four protocols above did not address.

• The five-part template proposed above is offered as a general design pattern. Critically evaluate it: what failure modes or blind spots might it still be vulnerable to, even when followed rigorously, and how would you strengthen it further?

Looking Forward

We now have not just individual tools, but complete, buildable research protocols, assembled from those tools according to a reusable, methodologically sound design template. Chapter 27 closes Part IV by returning, one final time, to the statistical foundations first laid in Chapter 12 - but now applied specifically to the machine-learning-heavy methodology this entire Part has introduced, addressing the specific new statistical pitfalls a researcher actually attempting to execute any of these protocols will need to navigate carefully.